Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology Ypsomed could include the supply of injection pens for CagriSema, the former’s ...
Ypsomed Holding AG (0QLQ – Research Report) received a Buy rating and a CHF400.00 price target from UBS analyst Tanya Hansalik today. The ...
The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback